Megabase-scale deletion using CRISPR/Cas9 to generate a fully haploid human cell line

被引:211
|
作者
Essletzbichler, Patrick [1 ]
Konopka, Tomasz [2 ]
Santoro, Federica [1 ]
Chen, Doris [2 ]
Gapp, Bianca V. [2 ]
Kralovics, Robert [2 ]
Brummelkamp, Thijn R. [2 ,3 ]
Nijman, Sebastian M. B. [1 ,2 ]
Buerckstuemmer, Tilmann [1 ]
机构
[1] Haplogen GmbH, A-7030 Vienna, Austria
[2] Austrian Acad Sci CeMM, Res Ctr Mol Med, A-7090 Vienna, Austria
[3] Netherlands Canc Inst, NL-7066 CX Amsterdam, Netherlands
关键词
EMBRYONIC STEM-CELLS; CHROMOSOMAL DELETIONS; GENETIC SCREENS; CAS9; INVERSIONS; NUCLEASES; CRISPR-CAS9; DERIVATION; LEUKEMIA;
D O I
10.1101/gr.177220.114
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Near-haploid human cell lines are instrumental for genetic screens and genome engineering as gene inactivation is greatly facilitated by the absence of a second gene copy. However, no completely haploid human cell line has been described, hampering the genetic accessibility of a subset of genes. The near-haploid human cell line HAP1 contains a single copy of all chromosomes except for a heterozygous 30-megabase fragment of Chromosome 15. This large fragment encompasses 330 genes and is integrated on the long arm of Chromosome 19. Here, we employ a CRISPR/Cas9-based genome engineering strategy to excise this sizeable chromosomal fragment and to efficiently and reproducibly derive clones that retain their haploid state. Importantly, spectral karyotyping and single-nucleotide polymorphism (SNP) genotyping revealed that engineered-HAPloid (eHAP) cells are fully haploid with no gross chromosomal aberrations induced by Cas9. Furthermore, whole-genome sequence and transcriptome analysis of the parental HAP1 and an eHAP cell line showed that transcriptional changes are limited to the excised Chromosome 15 fragment. Together, we demonstrate the feasibility of efficiently engineering megabase deletions with the CRISPR/Cas9 technology and report the first fully haploid human cell line.
引用
收藏
页码:2059 / 2065
页数:7
相关论文
共 50 条
  • [31] Large fragment deletion using a CRISPR/Cas9 system in Saccharomyces cerevisiae
    Hao, Huanhuan
    Wang, Xiaofei
    Jia, Haiyan
    Yu, Miao
    Zhang, Xiaoyu
    Tang, Hui
    Zhang, Liping
    ANALYTICAL BIOCHEMISTRY, 2016, 509 : 118 - 123
  • [32] Introduction of CALR mutations to a human erythroleukemia cell line, HEL, by CRISPR/Cas9 systems
    Yasuda, Shunichiro
    Aoyama, Satoru
    Watanabe, Daisuke
    Kawamata, Norihiko
    CANCER RESEARCH, 2018, 78 (13)
  • [33] Using CRISPR/Cas9 to model human liver disease
    Alves-Bezerra, Michele
    Furey, Nika
    Johnson, Collin G.
    Bissig, Karl-Dimiter
    JHEP REPORTS, 2019, 1 (05) : 392 - 402
  • [34] Establishment of a cloning-free CRISPR/Cas9 protocol to generate large deletions in the bovine MDBK cell line
    Joanna Stojak
    Dominique Rocha
    Caroline Mörke
    Christa Kühn
    Veronique Blanquet
    Hiroaki Taniguchi
    Journal of Applied Genetics, 2024, 65 : 399 - 402
  • [35] Establishment of a cloning-free CRISPR/Cas9 protocol to generate large deletions in the bovine MDBK cell line
    Stojak, Joanna
    Rocha, Dominique
    Moerke, Caroline
    Kuehn, Christa
    Blanquet, Veronique
    Taniguchi, Hiroaki
    JOURNAL OF APPLIED GENETICS, 2024, 65 (02) : 399 - 402
  • [36] Protocol for the Generation of Human Pluripotent Reporter Cell Lines Using CRISPR/Cas9
    Zhong, Aaron
    Li, Mu
    Zhou, Ting
    STAR PROTOCOLS, 2020, 1 (02):
  • [37] Targeted genome editing in a quail cell line using a customized CRISPR/Cas9 system
    Ahn, Jinsoo
    Lee, Joonbum
    Park, Ju Yeon
    Oh, Keon Bong
    Hwang, Seongsoo
    Lee, Chang-Won
    Lee, Kichoon
    POULTRY SCIENCE, 2017, 96 (05) : 1445 - 1450
  • [38] CRISPR/Cas9 mediated approach to generate YAP-depleted human embryonic stem cell line (MUSIe002-A-1)
    Khampang, Sujittra
    Jiamvoraphong, Nittaya
    Laowtammathron, Chuti
    Lorthongpanich, Chanchao
    Klaihmon, Phatchanat
    Srisook, Pimonwan
    Kang, Xing
    Luanpitpong, Sudjit
    U-pratya, Yaowalak
    Issaragrisil, Surapol
    STEM CELL RESEARCH, 2023, 66
  • [39] Loss of human corneal epithelial cell identity exhibited by deletion of PAX6 using the CRISPR/Cas9 system
    Kitazawa, Koji
    Hikichi, Takafusa
    Nakamura, Takahiro
    Sotozono, Chie
    Kinoshita, Shigeru
    Masui, Shinji
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
  • [40] Generation of an induced pluripotent stem cell line carrying a biallelic deletion (SCTCi019-A) in GCDH using CRISPR/Cas9
    Schuurmans, Imke M. E.
    Wu, Ka M.
    van Karnebeek, Clara D. M.
    Kasri, Nael Nadif
    Garanto, Alejandro
    STEM CELL RESEARCH, 2023, 69